Results

Pat Growth 25pctEbitda Margin CompressionEmphasis Of MatterRevenue Growth 20pctResults View source PDF Explain this filing

GANESHBE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.9%Reaction day

₹98.70

prior close

₹99.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-2.3% vs market

Oil peers, median of 16sector · industry level-2.3%-0.7% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 0.7 pts less than its Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.1

10m

-3.0

15m

-1.8

30m

-4.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.9-0.6-2.3-2.3-0.7

Next day

-5.5-1.7-3.8-2.5-3.0

-4.8-0.7-4.1-1.0-3.8

-4.1-0.4-3.7-0.3-3.8

+3.3+0.4+2.9-0.7+4.1

+13.6+0.4+13.1-0.8+14.4

+11.1+0.3+10.8-1.8+13.0

15d

+8.3+5.5+2.8-2.7+11.0

+4.2+4.6-0.4-4.9+9.1

+24.2+5.3+18.9-3.8+28.0

+16.5+11.6+5.0+14.4+2.1

UpDownMarket · Nifty Microcap 250Sector · Oil peers, median of 16Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ganesh Benzoplast reported consolidated revenue of Rs. 4,114.19 million for FY26, up 9.9% from Rs. 3,743.11 million in FY25. Net profit after tax grew significantly to Rs. 733.36 million compared to Rs. 380.86 million in FY25, representing a 92.5% increase. However, EBITDA margin compressed from 32.1% to 27.2% year-on-year due to higher operating expenses. The auditors issued an unmodified opinion on both standalone and consolidated results. An emphasis of matter was raised regarding an FIR and EOW complaint against the company and its directors/KMPs related to alleged unauthorized loans and borrowings by a former director of GBL Chemical Ltd (WOS) in FY 2023-24; the company has filed a petition for quashing the FIR which is pending in Delhi High Court. The company also announced plans to form a foreign wholly-owned subsidiary in Singapore.

Likely market impact

Strong PAT growth of 92.5% driven partly by exceptional items reversal is positive, but EBITDA margin compression of ~5 percentage points signals rising cost pressures. The unresolved legal matter (FIR/EOW complaint) adds regulatory risk and warrants monitoring.